8:02 am Halozyme announces Roche (RHHBY) marketing authorization for MabThera SC for patients with common forms of non-Hodgkin lymphoma in European Union

8:02 am Halozyme announces Roche (RHHBY) marketing authorization for MabThera SC for patients with common forms of non-Hodgkin lymphoma in European Union

more

View todays social media effects on HALO

View the latest stocks trending across Twitter. Click to view dashboard

See who Halozyme is hiring next, click here to view

Share this post